DailyIQ
|
Sector:Financial ServicesAll sectors
Last updated 24 minutes ago

MRSH·MRSH

$.
+. (+.%)
After Hours
High
$174.77
Open
$172.25
Market Cap
84.27B
52W High
$193.32
Low
$172.25
P. Close
$164.12
P/E
20.26
52W Low
$170.37
Fwd P/E
-
Mean Target
-
Technical Score (1D)
23
SELL
News Sentiment
50
MIXED
Marsh & McLennan (MRSH) has appointed Lisa Quest as UK CEO, a move that integrates consulting and insurance operations, which could reshape the UK commercial agenda. Quest will retain her role at Oliver Wyman, linking consulting capabilities with UK insurance and risk services. This leadership change, following Chris Lay's retirement, emphasizes data-driven client solutions. The company's recent share performance has been mixed, with a recent pullback, suggesting a potential weakening of recent momentum. Analysts maintain a cautiously optimistic view of MRSH, despite recent underperformance relative to the broader market, hinging on the company's anticipated long-term growth and earnings stability. Mercer, a Marsh business, found that US employees are staying with their current employers due to economic and AI anxieties, which could impact demand for consulting services. Morningstar's analysis highlights MRSH's diverse revenue streams, with significant international exposure, which may offer resilience but also introduces complexities. Traders should monitor how the integration of consulting and insurance services impacts MRSH's client relationships and financial performance in the UK.
Earnings Summary
Marsh & McLennan Companies, Inc. (MRSH), a financial services company, provides advisory services and insurance solutions globally, operating through Risk and Insurance Services and Consulting segments, serving various businesses and individuals in the insurance sector. The company's industry is insurance brokers. In the last two quarters, MRSH's earnings have shown mixed results. Q1 2025 saw an EPS of $3.06, exceeding the estimate of $2.99779, with revenue at $7.061 billion. However, the subsequent quarter, Q1 2026, lacks actual EPS and revenue data, though the revenue estimate is $7.424 billion. The company has shown a pattern of beating estimates in the last reported quarter. Examining the historical data, there is not enough information to analyze YoY growth trajectory or notable beats/misses. Recent news indicates Marsh & McLennan Agency (MMA) acquired Robinson & Son, expanding its offerings, and launched Secure Harbor, a group captive insurance solution, demonstrating a strategic focus on expanding service offerings. Investors should watch for the actual Q1 2026 earnings results and how the integration of recent acquisitions impacts future earnings reports.

EPS

EstBeatMiss
$2.95$3.05$3.14$3.24$3.33Q1'25Q1'26
QtrEstActual+/−
Q1'26$3.29$3.29-0.0%
Q1'25$3.00$3.06+2.1%

Revenue

EstBeatMiss
$7.0B$7.2B$7.3B$7.5B$7.7BQ1'25Q1'26
QtrEstActual+/−
Q1'26$7.6B$7.6B+0.5%
Q1'25 - $7.1B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

MRSH Stock Snapshot

MRSH is currently trading at $164.12, giving MRSH a market cap of 84.27B and a P/E ratio of 20.3. Today's range spans $172.25–$174.77, with shares opening at $172.25 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 23/100 (SELL) with a news sentiment reading of 50/100.

Over the past year MRSH has traded between $170.37 and $193.32 - the current price is -3.7% off the 52-week low and -15.1% from the high.

The path of least resistance for MRSH (MRSH) is currently lower - 23/100 (SELL), neutral sentiment (50/100), price $164.12 (near 52-week lows within $170.37–$193.32). The current P/E ratio stands at 20.3. At 84.27B in Financial Services market cap, this large-cap name is in the zone where portfolio risk managers - not just traders - are making decisions. Trimming positions on technical deterioration is standard practice at this size, and the current setup gives them a clear rationale to act.

Analyst coverage for MRSH becomes a double-edged factor in a SELL phase: at 84.27B in Financial Services market cap, active coverage is high enough that downgrade risk is real and impactful. The 23/100 technical reading and neutral sentiment (50/100) at $164.12 (near 52-week lows) place the stock in the zone where one or two high-profile estimate cuts can convert a grinding decline into a sharper re-rating — the $170.37–$193.32 range establishes where that repricing lands.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles
Loading latest news…